Source:http://linkedlifedata.com/resource/pubmed/id/15915152
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2005-6-2
|
pubmed:abstractText |
The focus of innovation in current drug discovery is on new targets, yet compound efficacy and safety in biological models of disease - not target selection - are the criteria that determine which drug candidates enter the clinic. We consider a biology-driven approach to drug discovery that involves screening compounds by automated response profiling in disease models based on complex human-cell systems. Drug discovery through cell systems biology could significantly reduce the time and cost of new drug development.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1474-1776
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
4
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
461-7
|
pubmed:dateRevised |
2007-2-15
|
pubmed:meshHeading |
pubmed-meshheading:15915152-Animals,
pubmed-meshheading:15915152-Cells, Cultured,
pubmed-meshheading:15915152-Drug Delivery Systems,
pubmed-meshheading:15915152-Humans,
pubmed-meshheading:15915152-Pharmaceutical Preparations,
pubmed-meshheading:15915152-Systems Biology,
pubmed-meshheading:15915152-Technology, Pharmaceutical
|
pubmed:year |
2005
|
pubmed:articleTitle |
Can cell systems biology rescue drug discovery?
|
pubmed:affiliation |
Department of Pathology, Stanford University, Stanford, California 94305-5324, USA. ebutcher@stanford.edu
|
pubmed:publicationType |
Journal Article,
Review
|